Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Nuclear Medicine

  Free Subscription


Articles published in J Neurol Neurosurg Psychiatry

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    April 2018
  1. MIHOVILOVIC MI, Kertels O, Hanscheid H, Lohr M, et al
    O-(2-((18)F)fluoroethyl)-L-tyrosine PET for the differentiation of tumour recurrence from late pseudoprogression in glioblastoma.
    J Neurol Neurosurg Psychiatry. 2018 Apr 28. pii: jnnp-2017-317155.
    PubMed     Text format    


    October 2017
  2. CHARIDIMOU A, Farid K, Tsai HH, Tsai LK, et al
    Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance.
    J Neurol Neurosurg Psychiatry. 2017 Oct 25. pii: jnnp-2017-316851.
    PubMed     Text format     Abstract available


  3. CARSWELL CJ, Win Z, Muckle K, Kennedy A, et al
    Clinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patients.
    J Neurol Neurosurg Psychiatry. 2017 Oct 10. pii: jnnp-2017-316194.
    PubMed     Text format     Abstract available


  4. MAKARETZ SJ, Quimby M, Collins J, Makris N, et al
    Flortaucipir tau PET imaging in semantic variant primary progressive aphasia.
    J Neurol Neurosurg Psychiatry. 2017 Oct 6. pii: jnnp-2017-316409.
    PubMed     Text format     Abstract available


    September 2017
  5. JOLING M, van den Heuvel OA, Berendse HW, Booij J, et al
    Serotonin transporter binding and anxiety symptoms in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Sep 12. pii: jnnp-2017-316193.
    PubMed     Text format     Abstract available


  6. NICCOLINI F, Pagano G, Fusar-Poli P, Wood A, et al
    Striatal molecular alterations in HD gene carriers: a systematic review and meta-analysis of PET studies.
    J Neurol Neurosurg Psychiatry. 2017 Sep 9. pii: jnnp-2017-316633.
    PubMed     Text format     Abstract available


    July 2017
  7. MCKIERNAN EF, O'Brien JT
    7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature.
    J Neurol Neurosurg Psychiatry. 2017;88:564-574.
    PubMed     Text format     Abstract available


    June 2017
  8. NISHIO Y, Yokoi K, Uchiyama M, Mamiya Y, et al
    Deconstructing psychosis and misperception symptoms in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jun 9. pii: jnnp-2017-315741.
    PubMed     Text format     Abstract available


    April 2017
  9. FIRBANK MJ, Yarnall AJ, Lawson RA, Duncan GW, et al
    Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.
    J Neurol Neurosurg Psychiatry. 2017;88:310-316.
    PubMed     Text format     Abstract available


    March 2016
  10. ERRO R, Schneider SA, Stamelou M, Quinn NP, et al
    What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.
    J Neurol Neurosurg Psychiatry. 2016;87:319-23.
    PubMed     Text format     Abstract available


    February 2016
  11. IWADATE Y, Shinozaki N, Matsutani T, Uchino Y, et al
    Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography.
    J Neurol Neurosurg Psychiatry. 2016 Feb 4. pii: jnnp-2015-311516.
    PubMed     Text format     Abstract available


    November 2015
  12. SMITH KM, Xie SX, Weintraub D
    Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease.
    J Neurol Neurosurg Psychiatry. 2015 Nov 3. pii: jnnp-2015-311827.
    PubMed     Text format     Abstract available


    January 2015
  13. HEYDRICH L, Marillier G, Evans N, Blanke O, et al
    Lateralising value of experiential hallucinations in temporal lobe epilepsy.
    J Neurol Neurosurg Psychiatry. 2015 Jan 13. pii: jnnp-2014-309452.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: